Bicycle Therapeutics (BCYC) Current Assets (2018 - 2026)

Bicycle Therapeutics' Current Assets history runs 9 years deep, the most recent figure standing at $619.1 million for Q1 2026.

• Quarterly Current Assets fell 27.68% year-over-year to $619.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $619.1 million (down 27.68% YoY) and the FY2025 annual result came in at $682.9 million, down 26.46% from the prior year.
• Current Assets was $619.1 million for Q1 2026 at Bicycle Therapeutics, down from $682.9 million in the prior quarter.
• Across five years, Current Assets topped out at $1.0 billion in Q2 2024 and bottomed at $369.4 million in Q4 2022.
• A 5-year average of $628.5 million and a median of $603.0 million in 2023 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2024 — Current Assets jumped 151.76% — and 2026, when it slipped 27.68%.
• Bicycle Therapeutics' Current Assets stood at $369.4 million in 2022, then jumped by 52.11% to $561.9 million in 2023, then soared by 65.27% to $928.6 million in 2024, then slipped by 26.46% to $682.9 million in 2025, then declined by 9.34% to $619.1 million in 2026.
• Business Quant data shows BCYC's Current Assets at $619.1 million in Q1 2026, $682.9 million in Q4 2025, and $738.8 million in Q3 2025.